Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.1000
-0.0150 (-13.04%)
Jun 10, 2026, 9:39 AM EST
Lobe Sciences Income Statement
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
| - | - | 0.14 | 0.84 | - | - | |
Revenue Growth (YoY) | - | - | -83.80% | - | - | - |
Cost of Revenue | - | - | 0.02 | 0.02 | - | - |
Gross Profit | - | - | 0.12 | 0.82 | - | - |
Selling, General & Admin | 3.27 | 3.01 | 1.51 | 2.58 | 3.07 | 4.08 |
Research & Development | 2.74 | 0.64 | 0.39 | 1.25 | 0.42 | 1.37 |
Amortization of Goodwill & Intangibles | - | - | 0.08 | 0.04 | 0.01 | - |
Operating Expenses | 6.74 | 4.18 | 2.25 | 4.18 | 4.12 | 6.38 |
Operating Income | -6.74 | -4.18 | -2.13 | -3.36 | -4.12 | -6.38 |
Interest Expense | -0.05 | -0.27 | -0.09 | -0.02 | - | - |
Interest & Investment Income | 0.19 | 0.06 | - | - | 2.2 | 1.57 |
Earnings From Equity Investments | - | - | - | -0.02 | -0.28 | -0.09 |
Currency Exchange Gain (Loss) | 0.05 | -0.08 | -0 | -0.12 | -0.11 | -0.11 |
Other Non Operating Income (Expenses) | -0.71 | -0.69 | -0.15 | 0.02 | -9.73 | -8.45 |
EBT Excluding Unusual Items | -7.26 | -5.17 | -2.37 | -3.49 | -12.05 | -13.46 |
Gain (Loss) on Sale of Investments | - | - | - | -0.66 | -0.2 | -0.46 |
Asset Writedown | - | - | -2.59 | - | - | -7.35 |
Other Unusual Items | 0.21 | 0.3 | 0.58 | -0.35 | - | -2.58 |
Pretax Income | -7.05 | -4.86 | -4.39 | -4.5 | -12.25 | -23.84 |
Income Tax Expense | - | - | 0.03 | 0.21 | - | -1.02 |
Earnings From Continuing Operations | -7.05 | -4.86 | -4.42 | -4.71 | -12.25 | -22.82 |
Earnings From Discontinued Operations | - | - | - | - | - | 13.16 |
Net Income to Company | -7.05 | -4.86 | -4.42 | -4.71 | -12.25 | -9.66 |
Minority Interest in Earnings | 1.43 | 0.43 | - | - | - | - |
Net Income | -5.62 | -4.43 | -4.42 | -4.71 | -12.25 | -9.66 |
Net Income to Common | -5.62 | -4.43 | -4.42 | -4.71 | -12.25 | -9.66 |
Shares Outstanding (Basic) | 183 | 139 | 122 | 104 | 38 | 32 |
Shares Outstanding (Diluted) | 183 | 139 | 122 | 104 | 38 | 33 |
Shares Change (YoY) | 5.98% | 13.58% | 17.04% | 175.61% | 15.91% | 160.26% |
EPS (Basic) | -0.03 | -0.03 | -0.04 | -0.05 | -0.32 | -0.30 |
EPS (Diluted) | -0.03 | -0.03 | -0.04 | -0.05 | -0.32 | -0.32 |
Gross Margin | - | - | 87.41% | 97.14% | - | - |
Operating Margin | - | - | -1564.93% | -399.67% | - | - |
Profit Margin | - | - | -3245.64% | -560.04% | - | - |
EBITDA | - | -4.09 | -2.05 | -3.32 | -4.11 | -6.16 |
D&A For EBITDA | - | 0.08 | 0.08 | 0.04 | 0.01 | 0.22 |
EBIT | -6.74 | -4.18 | -2.13 | -3.36 | -4.12 | -6.38 |
Advertising Expenses | - | 0.02 | 0.01 | 0.29 | 0.25 | 1.7 |